CMB-OC: Single-dose domestic bivalent HPV16/18 vaccination impact on vaccine efficacy and cervical cancer screening among young adult women in China

A randomized, blinded trial to assess the efficacy of a single-dose regimen of a domestic HPV vaccine against HPV-16/18 incident infections that persist six months or longer, in Chinese women ages 18-26.
Grant dates: January 1, 2022 to January 1, 2022
Amount: $80,000
Related Program: Health Policy and Systems Sciences
Related Program: Peking Union Medical College
Region: China
Grant Number: 21-420
Year: 2021
Principal Investigator: